Top section
Top section
High yields and tight senior/sub spread fuel enthusiasm for issuance among investors and issuers
◆ Pair help market to end week on a high note ◆ GSK offers pick-up over peer AstraZeneca ◆ Glencore finds demand at eight years
◆ French borrower takes €1.15bn across two tranches ◆ Balance struck between size and price to keep investors onside ◆ Small concession offered
Data
More articles
More articles
More articles
-
Earnings blackouts and higher funding costs to supress April supply -
After nearly barren week, issuance could return after Easter but all depends on headlines
-
◆ French firm raises €1bn with week's only deal so fair ◆ Books more than six times covered at close ◆ Slim premium offered — if any
-
World first deals could break new ground in sport risk management
-
A prolonged oil shock will hurt airlines, but a Covid-style industry collapse is a long way off
-
Talk of de-dollarisation has evaporated. The dollar market remains the undisputed king of financing
Sub-sections
